59746 383 06
Terazosin Hydrochloride Capsule
Product Images NDC 68788-9817
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 68788-9817). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
59746 384 06
This is a description of Terazosin Hydrochloride capsules, a medication used for treating high blood pressure and benign prostatic hyperplasia (BPH). The package contains 2mg capsules of Terazosin Hydrochloride equivalent, generic for Hytrin. The medication is produced by Jubilant Cadista Pharmaceuticals Inc. with each capsule containing terazosin-Hydrochloride. The text also has instructions regarding the warning that prohibits the transfer of medication prescribed to others. The text contains the batch number, the expiry date, and the National Drug Code (NDC) number.*
59746 385 06
Terazosin Hydrochloride Capsules are a medication used for treating symptoms of an enlarged prostate. Each capsule contains 5mg of Terazosin Hydrochloride and is a generic version of the medication Hytrin. The medication should only be taken by the patient it was prescribed for as the transfer of medication to others is prohibited under federal law. The medication is manufactured by Jubilant Cadista Pharmaceuticals and comes in a package size of 5. The expiration date and lot number are also provided.*
Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)
Figure 1 (Terazosin Hydrochloride Capsules 2)
Figure 2 (Terazosin Hydrochloride Capsules 3)
The text appears to be a table indicating the mean change from baseline over a period of time, with measurements taken at month 0, 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, and 30. However, without additional context or information, it is difficult to determine what the baseline and changes are referring to.*
Figure 3 (Terazosin Hydrochloride Capsules 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
